Open Access
| Issue |
Med Sci (Paris)
Volume 39, Number 11, Novembre 2023
|
|
|---|---|---|
| Page(s) | 813 - 815 | |
| Section | Nouvelles | |
| DOI | https://doi.org/10.1051/medsci/2023149 | |
| Published online | 29 November 2023 | |
- Buonfiglioli A, Hambardzumyan D. Macrophages and microglia: the cerberus of glioblastoma. Acta Neuropathol Commun 2021; 9 : 54. [CrossRef] [PubMed] [Google Scholar]
- Bausart M, Preat V, Malfanti A. Immunotherapy for glioblastoma: the promise of combination strategies. J Exp Clin Cancer Res 2022; 41 : 35. [CrossRef] [PubMed] [Google Scholar]
- Yum S, Li M, Chen ZJ. Old dogs, new trick: classic cancer therapies activate cGAS. Cell Res 2020; 30 : 639–48. [CrossRef] [PubMed] [Google Scholar]
- Chanut R, Petrilli V. Détection de l’ADN cytosolique par la voie cGAS-STING : de l’immunité innée au contrôle de la tumorigenèse. Med Sci (Paris) 2019 ; 35 : 527–534. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
- Bacar H, Michallet MC. La voie cGAS-STING : une nouvelle arme « innée » contre le cancer. Med Sci (Paris) 2021; 37 : 677–80. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
- Taffoni C, Marines J, Chamma H, et al. DNA damage repair kinase DNA-PK and cGAS synergize to induce cancer-related inflammation in glioblastoma. EMBO J 2023; 42 : e111961. [CrossRef] [PubMed] [Google Scholar]
- Xia T, Konno H, Ahn J, Barber GN. Deregulation of STING signaling in colorectal carcinoma constrains DNA damage responses and correlates with tumorigenesis. Cell Rep 2016 ; 14 : 282–297. [CrossRef] [PubMed] [Google Scholar]
- Falahat R, Berglund A, Putney RM, et al. Epigenetic reprogramming of tumor cell-intrinsic STING function sculpts antigenicity and T cell recognition of melanoma. Proc Natl Acad Sci USA 2021; 118. [CrossRef] [PubMed] [Google Scholar]
- Berger G, Knelson EH, Jimenez-Macias JL, et al. STING activation promotes robust immune response and NK cell-mediated tumor regression in glioblastoma models. Proc Natl Acad Sci USA 2022; 119 : e2111003119. [CrossRef] [PubMed] [Google Scholar]
- Lan T, Zhao Z, Qu Y, et al. Targeting hyperactivated DNA-PKcs by KU0060648 inhibits glioma progression and enhances temozolomide therapy via suppression of AKT signaling. Oncotarget 2016 ; 7 : 55555–55571. [CrossRef] [PubMed] [Google Scholar]
- Timme CR, Rath BH, O’Neill JW, et al. The DNA-PK inhibitor VX-984 enhances the radiosensitivity of glioblastoma cells grown in vitro and as orthotopic xenografts. Mol Cancer Ther 2018 ; 17 : 1207–1216. [CrossRef] [PubMed] [Google Scholar]
- Fang X, Huang Z, Zhai K, et al. Inhibiting DNA-PK induces glioma stem cell differentiation and sensitizes glioblastoma to radiation in mice. Sci Transl Med 2021; 13. [PubMed] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.